Albert David Ltd. — Investor Relations & Filings
Albert David Ltd. specializes in the manufacturing and marketing of pharmaceutical formulations, infusions, and herbal preparations. The company’s product portfolio encompasses a wide range of therapeutic segments, including anti-infectives, gastrointestinal agents, and ophthalmic solutions. A significant area of expertise lies in the production of large and small volume parenterals and specialized placenta extract-based treatments used for tissue regeneration and wound healing. The organization maintains advanced production facilities and focuses on research and development to support its diverse clinical offerings. Its operations serve a broad spectrum of healthcare needs across various global markets, emphasizing quality control and technical precision in its manufacturing processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | |
| Trading Window | 2026-03-23 | English | |
| Copy of Newspaper Publication | 2026-03-13 | English | |
| Copy of Newspaper Publication | 2026-03-11 | English | |
| Cessation | 2026-03-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 42199383 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | ||
| 42201053 | Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | ||
| 42205449 | Trading Window | 2026-03-23 | English | ||
| 42196147 | Copy of Newspaper Publication | 2026-03-13 | English | ||
| 42172583 | Copy of Newspaper Publication | 2026-03-11 | English | ||
| 42177873 | Cessation | 2026-03-10 | English | ||
| 42188184 | Copy of Newspaper Publication | 2026-02-12 | English | ||
| 42210300 | Integrated Filing- Financial | 2026-02-11 | English | ||
| 42211303 | Outcome of Board Meeting | 2026-02-11 | English | ||
| 43879736 | Board Meeting — Board Meeting Intimation | 2026-02-02 | English | ||
| 43879757 | Board Meeting — Financial Results | 2026-02-02 | English | ||
| 42209826 | Change in Management | 2026-01-17 | English | ||
| 42233902 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-01-05 | English | ||
|
2025
2 filings
| |||||
| 42232770 | Trading Window | 2025-12-22 | English | ||
| 42233724 | Trading Window | 2025-12-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHOSA Oncology AB
Develops diagnostics and therapeutics for platinum-based ch…
|
CHOSA | SE | Manufacturing |
|
CHUGAI PHARMACEUTICAL CO., LTD.
A research-driven pharmaceutical company developing innovat…
|
4519 | JP | Manufacturing |
|
CHUKYOIYAKUHIN CO.,LTD.
Offers health products and pharmaceuticals via a direct-to-…
|
4558 | JP | Manufacturing |
|
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Specialized manufacturer of APIs for oncology, antifungal, …
|
1762 | TW | Manufacturing |
|
Cian Healthcare Limited
WHO-GMP certified manufacturer of diverse healthcare produc…
|
542678 | IN | Manufacturing |
|
Cidara Therapeutics, Inc.
Develops targeted immunotherapies and anti-infectives for s…
|
CDTX | US | Manufacturing |
|
CILO CYBIN HOLDINGS LIMITED
Vertically integrated medical cannabis company with GACP cu…
|
CCCE | ZA | Manufacturing |
|
Cinclus Pharma Holding AB
Clinical-stage pharma company developing a PCAB for gastric…
|
CINPHA | SE | Manufacturing |
|
Cingulate Inc.
A clinical-stage biopharma firm developing treatments for A…
|
CING | US | Manufacturing |
|
Cipher Pharmaceuticals Inc.
Specialty pharmaceutical company acquiring and marketing pr…
|
CPHRF | CA | Manufacturing |
Albert David Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60428/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60428 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60428 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60428 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60428}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Albert David Ltd. (id: 60428)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.